Full brand integration to strengthen “One Freudenberg Medical” as a vertically integrated, strategic partner to global MedTech companies
Hemoteq AG has been part of the Freudenberg Medical Group of companies since 2015. During this time, Hemoteq has successfully operated under a dual-brand strategy as Hemoteq – a company of Freudenberg Medical. This approach ensured continuity for customers and partners while enabling close operational and strategic integration.
In 2025, the Freudenberg Group became the sole owner of Hemoteq AG. Hemoteq transitioned to the Freudenberg Medical brand in January 2026 to reflect the fully integrated organization and to further strengthen a unified market presence.
“This brand transition underscores the strength of ‘One Freudenberg Medical’. By uniting our vertically integrated capabilities – from advanced medical coatings, silicone, thermoplastic, and metal components, to the development and manufacturing of minimally invasive medical devices – under one strong brand, we create clarity in the market, transparency for our partners, and a consistent customer experience worldwide.”
Dr. Kai Opdenwinkel,
General Manager Coatings at Freudenberg Medical
Product brands remain established and clear
For more than two decades, Hemoteq has been a trusted partner to the MedTech industry, delivering proprietary drug-coating solutions and in-house developed coating technologies for numerous drug-eluting stents and drug-coated balloons. These innovations have contributed to therapies that have improved the lives of millions of patients worldwide.
While the company brand will transition to Freudenberg Medical, Hemoteq’s well-established product brands will remain unchanged:
will continue to be used as the product brand for drug coatings
will be used as the product brand for hydrophilic coatings
This approach ensures continuity for customers while clearly differentiating specialized coating technologies within the broader Freudenberg Medical portfolio.
Transition period and visual identity
To support a smooth transition, a 12-month co-branding phase is planned throughout 2026. During this period, a co-branded logo will be used across relevant touchpoints, helping customers and partners gradually adapt to the new visual identity.
Customers and partners have already been informed about the legal entity name change from Hemoteq AG to Freudenberg Medical Hemoteq GmbH. Business operations, contractual relationships, and points of contact remain unchanged.
With this step, Freudenberg Medical reinforces its commitment to clarity, consistency, and long-term partnership – bringing together deep materials expertise, precision device manufacturing capabilities, and leading medical coating technologies under one global brand.
